Find Funding Opportunities

The purpose of this notice is to inform applicants of a change to the Eligibility Information for RFA-Ns-22-050 "HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)". The Funding Opportunity Announcement (FOA) has been modified to show that "foreign components, as defined in the NIH Grants Policy Statement, are allowed.

The purpose of this notice is to add NINDS-specific research interests in PAS-22-196 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)".

The purpose of this notice is to add NINDS-specific research interests in PAS-22-197 "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)".

The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-20-049 "NINDS Postdoctoral Mentored Career Development Award (K01 - No Independent Clinical Trial Allowed)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round.

The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-20-050 "NINDS Postdoctoral Mentored Career Development Award (K01 - Clinical Trial Required)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round.

The purpose of this notice is to inform applicants of a correction to the Eligibility Information for RFA-NS-22-011 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed). For this Funding Opportunity Announcement (FOA), "Section III. Eligibility Information" has been corrected to allow intramural participation. This is consistent with the intramural participation language in "Section IV. Application and Submission Information, 7. Other Submission Requirements and Information".

The purpose of this time-sensitive Request for Information (RFI) is to seek input on the Draft ALS Strategic Plan from people living with amyotrophic lateral sclerosis (ALS), families, caregivers, people with genetic risk of ALS, advocates, scientists, clinicians, and the broader community.

The purpose of this notice is to inform applicants of a change to the Key dates and review locus for RFA-NS-19-043 "BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round.

The purpose of this notice is to inform applicants of a change to the Key dates and review locus for RFA-NS-19-044 "BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round.

On October 11, 2022, the National Institute on Drug Abuse and BRAIN Initiative published the Funding Opportunity Announcement, RFA-DA-23-030, BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Not Allowed) to solicit applications supporting planning activities that will lay the groundwork for a scientific projects aiming to 1) develop and apply cutting-edge tools and methods for minimally invasive, multi-dimensional, high-resolution measurement of behavior at the level of the organism, with synchronous capture of data from the environment; and/or 2) develop computational methods that allow for integration of multidimensional behavioral and environmental data into a conceptual and/or computational model of behavior as a complex dynamic system. This Notice provides information regarding two upcoming Pre-Application Webinars for the above-referenced FOA. At these Webinars, Program and Review Officials from NIDA and other institutes participating in the BRAIN Initiative will provide a brief overview of this RFA and address questions from prospective applicants. Webinar Information Option 1 Date: Tuesday, November 22, 2022, Time: 11 am EST The webinar will be hosted through Zoom. Participants must register in advance for the webinar through the following link, after which a link to join the webinar will be e-mailed to the participant: NIH Zoom Webinar link: Option 2 Date: Monday, November 28, 2022, Time: 1 pm EST The webinar will be hosted through Zoom. Participants must register in advance for the webinar through the following link, after which a link to join the webinar will be e-mailed to the participant: NIH Zoom Webinar link: